FDA Center for Drug Evaluation & Research Issues Warning Letter to Woodbine Products
August 05, 2026
August 05, 2026
WASHINGTON, Aug. 5 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Woodbine Products Co. Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Stephen A. Kuzyk Jr., Secretary Treasurer, Woodbine Products Company Inc., 915 W. Smith Road, Medina, OH 44256-2446, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Wa . . .
* * *
Recipient: Mr. Stephen A. Kuzyk Jr., Secretary Treasurer, Woodbine Products Company Inc., 915 W. Smith Road, Medina, OH 44256-2446, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Wa . . .